nach oben

Journal of Echocardiography

Erschienen in:

01.09.2010 | Original Investigation

Relation between progression of aortic valve sclerosis and carotid intima–media thickening in asymptomatic subjects with cardiovascular risk factors

verfasst von: Yasuko Yamaura, Nozomi Watanabe, Kikuko Obase, Akihiro Hayashida, Hiroyuki Okura, Kiyoshi Yoshida

Erschienen in: Journal of Echocardiography | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Aortic valve sclerosis (AVS) is the early lesion of calcific aortic valve disease and may subsequently progress toward valvular stenosis. Histopathological and clinical evidence has suggested that AVS and atherosclerosis share similar mechanisms. However, little is known regarding the relation between the early AVS progression and the early atherosclerosis progression. The carotid intima–media thickness (IMT) by carotid ultrasonography has been established as the surrogate marker of the early atherosclerosis. The aim of this study was to examine the association between progression of early AVS and increase of carotid IMT.

Methods

We retrospectively analyzed the data of 127 asymptomatic subjects (49 ± 8 years, 114 men) with ≥1 cardiovascular (CV) risk factors, without history of CV disease, who underwent echocardiographic and carotid ultrasonographic examinations twice ≥6 months apart. We evaluated aortic valve morphology and function and carotid IMT at the baseline and at follow-up examinations.

Results

During a follow-up of 25 ± 15 months, the number of subjects with AVS was significantly increased (34 vs. 47%, P < 0.0001) and the mean value of carotid IMT was significantly increased (1.16 ± 0.33 vs. 1.29 ± 0.41 mm, P < 0.0001). The progression of AVS was observed in 26 subjects. By logistic regression analysis, the baseline carotid IMT value was an independent predictor of AVS progression (odds ratio = 4.07, P = 0.026).

Conclusion

In asymptomatic subjects with CV risk factors, progression of AVS and increase of carotid IMT were observed during a mean follow-up period of 25 months. Progression of AVS in asymptomatic subjects with CV risk factors was associated with carotid intima–media thickening.

Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O’Brien KD. Characterization of the early lesion of ‘degenerative’ valvular aortic stenosis. Histological and immunohistochemical studies. Circulation. 1994;90:844–53.PubMed

Olsson M, Dalsgaard CJ, Haegerstrand A, Rosenqvist M, Rydén L, Nilsson J. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol. 1994;23:1162–70.CrossRefPubMed

O’Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of ‘degenerative’ valvular aortic stenosis. Arterioscler Thromb Vasc Biol. 1996;16:523–32.PubMed

Cosmi JE, Kort S, Tunick PA, Rosenzweig BP, Freedberg RS, Katz ES, et al. The risk of the development of aortic stenosis in patients with “benign” aortic valve thickening. Arch Intern Med. 2002;162:2345–7.CrossRefPubMed

Faggiano P, Antonini-Canterin F, Erlicher A, Romeo C, Cervesato E, Pavan D, et al. Progression of aortic valve sclerosis to aortic stenosis. Am J Cardiol. 2003;91:99–101.CrossRefPubMed

Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation. 2005;111:3316–26.CrossRefPubMed

O’Brien KD, Kuusisto J, Reichenbach DD, Ferguson M, Giachelli C, Alpers CE, et al. Osteopontin is expressed in human aortic valvular lesions. Circulation. 1995;92:2163–8.PubMed

Mohler ER 3rd, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation. 2001;103:1522–8.PubMed

Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29:630–4.CrossRefPubMed

10.

Agmon Y, Khandheria BK, Meissner I, Sicks JR, O’Fallon WM, Wiebers DO, et al. Aortic valve sclerosis and aortic atherosclerosis: different manifestations of the same disease? Insights from a population-based study. J Am Coll Cardiol. 2001;38:827–34.CrossRefPubMed

11.

Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341:142–7.CrossRefPubMed

12.

Aronow WS, Ahn C, Shirani J, Kronzon I. Comparison of frequency of new coronary events in older subjects with and without valvular aortic sclerosis. Am J Cardiol. 1999;83:599–600.CrossRefPubMed

13.

Olsen MH, Wachtell K, Bella JN, Gerdts E, Palmieri V, Nieminen MS, et al. Aortic valve sclerosis relates to cardiovascular events in patients with hypertension (a LIFE substudy). Am J Cardiol. 2005;95:132–6.CrossRefPubMed

14.

Chandra HR, Goldstein JA, Choudhary N, O’Neill CS, George PB, Gangasani SR, et al. Adverse outcome in aortic sclerosis is associated with coronary artery disease and inflammation. J Am Coll Cardiol. 2004;43:169–75.CrossRefPubMed

15.

Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima–media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997;96:1432–7.PubMed

16.

O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 1999;340:14–22.CrossRefPubMed

17.

Yamaura Y, Nishida T, Watanabe N, Akasaka T, Yoshida K. Relation of aortic valve sclerosis to carotid artery intima–media thickening in healthy subjects. Am J Cardiol. 2004;94:837–9.CrossRefPubMed

18.

Wang AY, Ho SS, Wang M, Liu EK, Ho S, Li PK, et al. Cardiac valvular calcification as a marker of atherosclerosis and arterial calcification in end-stage renal disease. Arch Intern Med. 2005;165:327–32.CrossRefPubMed

19.

Sgorbini L, Scuteri A, Leggio M, Gianni W, Nevola E, Leggio F. Carotid intima–media thickness, carotid distensibility and mitral, aortic valve calcification: a useful diagnostic parameter of systemic atherosclerotic disease. J Cardiovascular Med. 2007;8:342–7.CrossRef

20.

Antonini-Canterin F, Di Bello V, Di Salvo G, La Carrubba S, Bellieni G, Benedetto F, et al. Relation of carotid intima–media thickness and aortic valve sclerosis (from the ISMIR study [“Ispessimento Medio Intimale e Rischio Cardiovascolare”] of the Italian Society of Cardiovascular Echography). Am J Cardiol. 2009;103:1556–61.CrossRefPubMed

21.

Bahler RC, Desser DR, Finkelhor RS, Brener SJ, Youssefi M. Factors leading to progression of valvular aortic stenosis. Am J Cardiol. 1999;84:1044–8.CrossRefPubMed

22.

Yamaura Y, Watanabe N, Iino Y, Tsukiji M, Obase K, Okahashi N, et al. Rapid progression of aortic valve stenosis in patients with chronic hemodialysis: report of two cases. J Echocardiogr. 2008;3:84–6.CrossRef

23.

Demircan S, Tekin A, Tekin G, Topçu S, Yiğit F, Erol T, et al. Comparison of carotid intima–media thickness in patients with stable angina pectoris versus patients with acute coronary syndrome. Am J Cardiol. 2005;96:643–4.CrossRefPubMed

24.

Yoshitani H, Takeuchi M, Ogawa K, Otsuji Y. Comparison of usefulness of the wall thickness of the left anterior descending coronary artery, determined by transthoracic echocardiography, and carotid intima–media thickness in predicting multivessel coronary artery disease. J Echocardiogr. 2009;7:2–8.CrossRef

25.

Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359:1343–56.CrossRefPubMed

26.

de Groot E, Jukema JW, Montauban van Swijndregt AD, Zwinderman AH, Ackerstaff RGA, van der Steen AF, et al. B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS). J Am Coll Cardiol. 1998;31:1561–7.CrossRefPubMed

27.

Crouse JR 3rd, Raichlen JS, Riley WA, Evans GW, Palmer MK, O’Leary DH, et al. Effect of rosuvastatin on progression of carotid intima–media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR trial. JAMA. 2007;297:1344–53.CrossRefPubMed

28.

Agmon Y, Khandheria BK, Jamil Tajik A, Seward JB, Sicks JD, Fought AJ, et al. Inflammation, infection, and aortic valve sclerosis: insights from the Olmsted County (Minnesota) population. Atherosclerosis. 2004;174:337–42.PubMed

29.

Imai K, Okura H, Kume T, Yamada R, Miyamoto Y, Kawamoto T, et al. C-reactive protein predicts severity, progression, and prognosis of asymptomatic aortic valve stenosis. Am Heart J. 2008;156:713–8.CrossRefPubMed

Titel: Relation between progression of aortic valve sclerosis and carotid intima–media thickening in asymptomatic subjects with cardiovascular risk factors
verfasst von: Yasuko Yamaura
Nozomi Watanabe
Kikuko Obase
Akihiro Hayashida
Hiroyuki Okura
Kiyoshi Yoshida
Publikationsdatum: 01.09.2010
Verlag: Springer Japan
Erschienen in: Journal of Echocardiography / Ausgabe 3/2010
Print ISSN: 1349-0222
Elektronische ISSN: 1880-344X
DOI: https://doi.org/10.1007/s12574-010-0038-9

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Relation between progression of aortic valve sclerosis and carotid intima–media thickening in asymptomatic subjects with cardiovascular risk factors